225 related articles for article (PubMed ID: 30425468)
1. Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3381-3387. PubMed ID: 30425468
[TBL] [Abstract][Full Text] [Related]
2. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
[TBL] [Abstract][Full Text] [Related]
4. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
5. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
7. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?
Sarioglu N; Hismiogullari AA; Bilen C; Erel F
Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740
[TBL] [Abstract][Full Text] [Related]
8. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
[TBL] [Abstract][Full Text] [Related]
9. IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients.
Savchenko L; Mykytiuk M; Cinato M; Tronchere H; Kunduzova O; Kaidashev I
Int J Chron Obstruct Pulmon Dis; 2018; 13():2569-2575. PubMed ID: 30197513
[TBL] [Abstract][Full Text] [Related]
10. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
Ishikawa N; Hattori N; Kohno N; Kobayashi A; Hayamizu T; Johnson M
Int J Chron Obstruct Pulmon Dis; 2015; 10():185-92. PubMed ID: 25670894
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
[TBL] [Abstract][Full Text] [Related]
12. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
13. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease.
Jin J; Yu W; Li S; Lu L; Liu X; Sun Y
Medicine (Baltimore); 2016 Jul; 95(29):e4219. PubMed ID: 27442646
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD.
Kerget B; Afşin DE; Kerget F; Koçak AO; Aksakal A; Kızıltunç A; Araz Ö; Yılmazel Uçar E; Akgün M
Tuberk Toraks; 2021 Mar; 69(1):30-38. PubMed ID: 33853303
[TBL] [Abstract][Full Text] [Related]
16. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
17. [Systemic inflammatory profile of smokers with and without COPD].
Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
[TBL] [Abstract][Full Text] [Related]
18. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
20. Sputum-to-serum hydrogen sulfide ratio in COPD.
Saito J; Mackay AJ; Rossios C; Gibeon D; Macedo P; Sinharay R; Bhavsar PK; Wedzicha JA; Chung KF
Thorax; 2014 Oct; 69(10):903-9. PubMed ID: 25035127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
